$203.72+23.81% · 3M
Moving avg
1W-0.51%
1M+1.46%
3M+25.82%
6M-4.17%
YTD-11.58%
1Y-3.09%
3Y-10.63%
5Y-27.91%
52-week range
$160.9352% of range$242.80
Company health
Value1/6
Growth2/6
Profitability5/6
Health5/6
Dividend4/6
Bull vs bear
Strengths
- Analyst consensus is "Buy"
- High return on equity (766%)
Risks
No obvious red flags from the metrics.
Key statistics
Valuation
Market cap
$143.21B
Enterprise value
$156.83B
P/E ratio (TTM)
33.89x
P/S ratio (TTM)
5.36x
EV/EBITDA
24.38x
Per share & returns
EPS (TTM)
$5.68
Dividend yield
0.75%
Beta (1Y)
0.82
30-day change
+1.46%
Trading
Volume (24h)
721.11K
Previous close
$205.79
Shares outstanding
702.99M
About Danaher Corporation
Sector
Healthcare
Industry
Medical - Diagnostics & Research
Exchange
NYSE
Symbol
DHR
Danaher Corporation is a large-cap healthcare company in the Medical - Diagnostics & Research industry. Its shares are listed on NYSE (United States) and trade under the ticker DHR.
Frequently asked questions
What is Danaher Corporation's market cap?
Danaher Corporation (DHR) has a market capitalization of $143.21B.
What is Danaher Corporation's P/E ratio?
Danaher Corporation trades at a price-to-earnings (P/E) ratio of 33.89.
What exchange does DHR trade on?
DHR trades on NYSE.
Appears in
Compare & explore
Eli Lilly and CompanyLLY
$1,217.61-0.22%
$1.15T cap
Johnson & JohnsonJNJ
$261.48+0.24%
$630.14B cap
AbbVie Inc.ABBV
$250.93+0.87%
$443.33B cap
UnitedHealth Group IncorporatedUNH
$402.36-0.80%
$365.40B cap
Roche Holding AGSWX: ROP
CHF 362.30-0.88%
$354.73B cap
Merck & Co., Inc.MRK
$134.62+1.28%
$332.49B cap
Novartis AGSWX: NOVN
CHF 123.74-0.37%
$289.30B cap
AstraZeneca PLCLON: AZN
£117.08+0.05%
$245.01B cap